NCT03323073

Brief Summary

The primary purpose is to compare with resting fMRI the functional networks of rest (RTS) in unipolar depression and in bipolar depression. Hypothesis : the main objective of this work is to compare with the rest fMRI the Rest Functional Networks (RFN) in the unipolar depression and in the bipolar depression in order to identify specific biomarkers for each affection. The general hypothesis of this work is that intra- and inter RFN connectivity is different between bipolar patients and unipolar patients. Specifically the investigators assume that connectivity within the default mode network (including ventral mediofrontal cortex, subgenual cingulate cortex, inferior parietal cortex, posterior cingulate cortex) will be increased in unipolar patients compared to bipolar patients.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2011

Longer than P75 for not_applicable

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 14, 2011

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 18, 2014

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 24, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 26, 2017

Completed
Last Updated

October 31, 2017

Status Verified

October 1, 2017

Enrollment Period

2.9 years

First QC Date

October 24, 2017

Last Update Submit

October 27, 2017

Conditions

Keywords

unipolarbipolardepressionresting state fMRIneural networkconnectivity

Outcome Measures

Primary Outcomes (1)

  • Bold signal and connectivity coefficients within and between neural networks

    Bold connectivity assessed with resting state fMRI within and between networks

    one day (within 16 days after inclusion)

Secondary Outcomes (2)

  • Correlations between clinical scores (MADRS, YMRS, SCID) and neural network connectivity.

    one day (within 16 days after inclusion)

  • Sensibility and specificity of fMRI to predict unipolar and bipolar depressive status

    one day (within 16 days after inclusion)

Study Arms (3)

Bipolar disorder type I or II

ACTIVE COMPARATOR

a single resting state fMR for patients with bipolar disorder type I or II with acute depressive state

Other: Resting state fMRI

Unipolar disorder

ACTIVE COMPARATOR

a single resting state fMR for patients with monopolar disorder with acute depressive state

Other: Resting state fMRI

Healthy volunteers

OTHER

a single resting state fMRI for subjects without psychiatric disorders assessed by the SCID

Other: Resting state fMRI

Interventions

One single fMRI which is used to characterize a uni or a bipolar major depressive episode (MDE).

Bipolar disorder type I or IIHealthy volunteersUnipolar disorder

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Unipolar and bipolar depressed patients including patients with type I and type II bipolar disorders.
  • Patients in an acute depressive state (according to DSM-IV criteria).
  • Men or Women with age between 18 to 65 years.
  • Patients with unipolar depression must fullfill Mitchel's criteria for unipolar depression.
  • MADRS score \> 22
  • YMRS score \< 12
  • Mean duration of depressive episode \< 1 year
  • in-patient or out-patient
  • Healthy volunteers matched for age and socio-educational level, without personal history of unipolar or bipolar depression and without psychiatric disorders

You may not qualify if:

  • Patients and controls:
  • Bipolar disorder with rapid cycling
  • Suicidal thoughts with score \> 3 at the MADRS item 'suicide'
  • Depression with psychotic features
  • Psychiatric co-morbidity including other AXIS-1 disorders (OCD, schizophrenia, social phobia) and borderline personality disorder
  • Substance and alcohol abuse or dependance
  • Recent treatment with ECT (\< 6 months)
  • Previous history of Brain Traumatic Injury; neurological disorders (multiple sclerosis, parkinson's disease, stroke) or disorders associated with abnormal MRI (lupus, Behcet's disease)
  • Contra-indication of MRI: pregnancy; tatoos; claustrophobia
  • Patient hospitalized under legal condition
  • Patient that requires an important sedation due to anxiety
  • Bipolar patients that requires at less 3 mood stabilizers
  • Patient receiving a new antidepressant since more than 10 days
  • Patients without social security insurance
  • Patients with legal protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Philippe FOSSATI, Professor

    AP-HP, Pitié-Salpêtrière Hospital of Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 24, 2017

First Posted

October 26, 2017

Study Start

December 14, 2011

Primary Completion

November 18, 2014

Study Completion

June 1, 2017

Last Updated

October 31, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share